Abbott Just Made a Big Bet on Cancer Screening
Abbott Laboratories (ABT) just finalized its $23 billion acquisition of Exact Sciences. Learn how this deal expands its diagnostic reach.
Read this issue
Tyler Jarman
8 Articles
Netflix’s Warner Bros. Discovery Deal and What it Means for NFLX Stock
Netflix’s all-cash Warner Bros. Discovery deal has investors questioning NFLX stock. Here’s what the acquisition really means for growth, ads, and long-term returns.
Read this issue
Home Depot’s Latest Earnings ‘Miss’ Looks More Like a Second Chance
Despite soft sales and a lowered outlook, Home Depot's long-term story hasn't changed. We break down the housing cycle, future demand, and why this "forever stock" may deserve another look.
Read this issue
Forget the Late-Night Talk Show Drama – Here’s What Really Matters for Disney’s Stock
Don't let late-night headlines distract you from Disney's (DIS) true value. We analyze how Parks, ESPN, and DTC profitability are driving the stock.
Read this issue
The Case for Lockheed Martin (LMT) as a Long-Term Stock Buy
Investing in war stocks is never a feel-good story – but it's often a profitable one. And among the top defense stocks to buy, Lockheed Martin stands alone.
Read this issue
Joby Aviation Stock Soars on Two Big Announcements… Should You Buy?
Joby Aviation (JOBY) is racing to launch electric air taxis with Toyota and Saudi backing. Can it win the eVTOL race?
Read this issue